387 related articles for article (PubMed ID: 19478225)
21. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.
Sun L; Zhou W; Mueller C; Sommer C; Heiland S; Bauer AT; Marti HH; Veltkamp R
J Cereb Blood Flow Metab; 2010 Sep; 30(9):1651-60. PubMed ID: 20424638
[TBL] [Abstract][Full Text] [Related]
22. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
[TBL] [Abstract][Full Text] [Related]
23. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y
J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371
[TBL] [Abstract][Full Text] [Related]
24. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.
Fan X; Lo EH; Wang X
Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086
[TBL] [Abstract][Full Text] [Related]
25. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
26. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
27. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
[TBL] [Abstract][Full Text] [Related]
28. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
[TBL] [Abstract][Full Text] [Related]
29. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
Kaur J; Tuor UI; Zhao Z; Barber PA
J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
[TBL] [Abstract][Full Text] [Related]
30. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
Houng AK; Wang D; Reed GL
Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
[TBL] [Abstract][Full Text] [Related]
31. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
32. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
[TBL] [Abstract][Full Text] [Related]
33. Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.
Gautier S; Ouk T; Tagzirt M; Lefebvre C; Laprais M; Pétrault O; Dupont A; Leys D; Bordet R
J Neuroinflammation; 2014 May; 11():96. PubMed ID: 24885160
[TBL] [Abstract][Full Text] [Related]
34. Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.
Tan Z; Li X; Turner RC; Logsdon AF; Lucke-Wold B; DiPasquale K; Jeong SS; Chen R; Huber JD; Rosen CL
Eur J Pharmacol; 2014 Sep; 738():368-73. PubMed ID: 24933645
[TBL] [Abstract][Full Text] [Related]
35. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
36. Normobaric Hyperoxia Reduces Blood Occludin Fragments in Rats and Patients With Acute Ischemic Stroke.
Shi S; Qi Z; Ma Q; Pan R; Timmins GS; Zhao Y; Shi W; Zhang Y; Ji X; Liu KJ
Stroke; 2017 Oct; 48(10):2848-2854. PubMed ID: 28931617
[TBL] [Abstract][Full Text] [Related]
37. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
[TBL] [Abstract][Full Text] [Related]
38. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
[TBL] [Abstract][Full Text] [Related]
39. Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis-induced Hemorrhagic Transformation in Ischemia-reperfused Rat Brains.
Chen HS; Chen XM; Feng JH; Liu KJ; Qi SH; Shen JG
CNS Neurosci Ther; 2015 Jul; 21(7):585-90. PubMed ID: 25996167
[TBL] [Abstract][Full Text] [Related]
40. Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.
Qin Z; Karabiyikoglu M; Hua Y; Silbergleit R; He Y; Keep RF; Xi G
Stroke; 2007 Apr; 38(4):1362-7. PubMed ID: 17322079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
